AAA
DTIL icon

Affinity Asset Advisors’s Precision BioSciences DTIL Stock Holding History

Affinity Asset Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.29M Buy
+597,946
New +$2.76M 0.17% 85

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Affinity Asset Advisors's DTIL Position: Q1 2026 in Review

Affinity Asset Advisors opened a new position in Precision BioSciences (DTIL) in Q1 2026: 597,946 shares worth $3.29M. The stake represents 0.17% of the portfolio and ranks #85 among its holdings.

78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Affinity Asset Advisors held 597,946 shares of Precision BioSciences worth $3.29M as of Q1 2026.
  • Precision BioSciences was a new Affinity Asset Advisors position in Q1 2026.
  • Precision BioSciences made up 0.17% of Affinity Asset Advisors's portfolio in Q1 2026, its #85 holding.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Affinity Asset Advisors's 13F filing for Q1 2026, filed 14 May 2026.